documented methylation in the SCARA5 promoter region of Hepatocellular carcinoma (HCC) cells, accounting for low SCARA5 expression and hence enhanced in vivo tumorigenicity, cell invasion, and tumor metastasis. This evidence concerns the gene SCARA5 and neoplasm.